Colombia’s New Pricing Decree Could Impact Drug Registration, Warns Industry Group

 
• By Francesca Bruce
Colombia
Colombia's Pharmaceutical Industry Association Calls For Pricing Decree to be Revised

More from Government Payers

More from Market Access